title: Cell-based therapies for diabetes: progress towards a transplantable human beta cell line.
abstract: Achieving normoglycemia is the goal of diabetes therapy. Potentially, there are many ways to achieve this goal, including transplantation of cells exhibiting glucose-responsive insulin secretion. However, to be applicable to the large number of people who might benefit from beta cell replacement, an unlimited supply of beta cells must be found. To address this problem, we have been developing cell lines from the human endocrine pancreas. In one case, a cell line, betalox5, has been developed from human islets that can be induced under some circumstances to differentiate into functional beta cells exhibiting appropriate glucose-responsive insulin secretion. Inducing differentiation is complex, requiring the activation of multiple signaling pathways, including those downstream of those involved in cell-cell contact and the glucagon-like peptide-1 receptor. In addition, transfer of the PDX-1 gene is also necessary to render the cells competent for differentiation. However, it is clear that many other genes are involved in maintaining the commitment of betalox5 cells towards the beta cell lineage. Understanding the complement of genes required to establish and maintain a beta cell lineage commitment would be enormously helpful in efforts to develop a cell line that can be used for beta cell replacement therapies. Here, we provide further information on the characteristics of cell lines that we have developed from the human pancreas that are relevant to the development of a beta cell replacement therapy for diabetes.
authors.affiliation: Cancer Center, University of California, San Diego, La Jolla, California 92093, USA.
authors.forename: Pamela
authors.initials: P
authors.lastname: Itkin-Ansari
authors.forename: Ifat
authors.initials: I
authors.lastname: Geron
authors.forename: Ergeng
authors.initials: E
authors.lastname: Hao
authors.forename: Carla
authors.initials: C
authors.lastname: Demeterco
authors.forename: Bjorn
authors.initials: B
authors.lastname: Tyrberg
authors.forename: Fred
authors.initials: F
authors.lastname: Levine
mesh_terms: D001483:Base Sequence; D002460:Cell Line; D017931:DNA Primers; D003920:Diabetes Mellitus / Q000628:therapy*; D006801:Humans; D016381:Islets of Langerhans Transplantation; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013234:Stem Cells
chemical_list: D017931:DNA Primers